Article Details
Retrieved on: 2025-02-07 16:39:01
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... FRONTIER3 trial. The company plans to file for approval this year, hoping to compete in the hemophilia A space with Roche's blockbuster Hemlibra.
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here